Watchlist Price Alert

Evaxion Biotech A/S (EVAX)

NASDAQ: EVAX · Real-Time Price · USD

2.21

0.14 (6.76%)

At close: Jun 18, 2025, 10:18 AM

Evaxion Biotech A/S Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-10.55M	-22.13M	-23.17M	-24.53M	-15.02M	-11.2M	-5.54M
Depreciation & Amortization	607.02K	615K	571K	344K	105K	81K	74K
Stock-Based Compensation	357K	479K	942K	1.38M	3.41M	2.36M	2.07M
Other Working Capital	-303K	-48.7K	-2.28M	1.88M	-1.58M	-7K	13K
Other Non-Cash Items	-3.06M	2.76M	-243K	-171K	919K	1.99M	1.16M
Deferred Income Tax	-813K	-984K	-998K	-190K	-2.07M	-825K	-735K
Change in Working Capital	520K	1.56M	-2.88M	1.24M	215K	566K	981K
Operating Cash Flow	-12.94M	-17.69M	-25.77M	-21.93M	-12.44M	-7.03M	-1.99M
Capital Expenditures	n/a	-87K	-292K	-1.36M	-393K	-61K	-7K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-3K	-6K	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	24.01K	29.95K	n/a	n/a	n/a
Other Investing Acitivies	n/a	133.00	-13	48.00	-244K	-7K	13K
Investing Cash Flow	-3K	-93K	-268K	-1.33M	-393K	-61K	6K
Debt Repayment	-1.14M	-632K	7.42M	-289K	n/a	79K	7.93M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-2.29M	2.15M	n/a	-3.76M	-202K	-13K	n/a
Financial Cash Flow	13.13M	10.69M	7.85M	49.8M	8.82M	9.51M	9.03M
Net Cash Flow	369K	-7.6M	-18.98M	26.33M	-3.73M	2.13M	6.96M
Free Cash Flow	-12.94M	-17.78M	-26.07M	-23.29M	-12.83M	-7.09M	-2M